Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Venous leg symptoms in patients with varicocele: A multicenter assessment study (VEIN-TURKEY study).

Ozturk S, Akbaba KT, Kılıc S, Cıcek T, Peskırcıoglu L, Tandogan I, Gurlek A, Aydemır O, Ilerı M, Yetkın E.

Phlebology. 2019 Mar;34(2):128-136. doi: 10.1177/0268355518777110. Epub 2018 May 24.

PMID:
29793400
2.
3.

Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study.

Ertaş FS, Tokgözoğlu L; EPICOR Study Group.

Anatol J Cardiol. 2016 Dec;16(12):900-915. doi: 10.14744/AnatolJCardiol.2016.6755. Epub 2016 Jun 29.

4.

Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?

Beton O, Saricam E, Kaya H, Yucel H, Dogdu O, Turgut OO, Berkan O, Tandogan I, Yilmaz MB.

BMC Cardiovasc Disord. 2016 Apr 22;16:73. doi: 10.1186/s12872-016-0251-1.

5.

Non-documented but induced supraventricular tachycardia: a new challenge or a new light?

Yetkin E, Tandogan I.

Europace. 2016 Feb;18(2):315. doi: 10.1093/europace/euv279. Epub 2015 Oct 31. No abstract available.

PMID:
26521292
6.

Tinnitus preceding tachycardia and syncope.

Yetkin E, Tandogan I.

Int J Cardiol. 2015 Nov 1;198:93-4. doi: 10.1016/j.ijcard.2015.06.180. Epub 2015 Jul 4. No abstract available.

PMID:
26159245
7.

Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns.

Bueno H, Sinnaeve P, Annemans L, Danchin N, Licour M, Medina J, Pocock S, Sánchez-Covisa J, Storey RF, Jukema JW, Zeymer U, Van de Werf F; EPICOR Investigators.

Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):3-12. doi: 10.1177/2048872614565912. Epub 2015 Jan 5.

PMID:
25561688
8.

Author`s Reply.

Zorkun C, Amioğlu G, Bektaşoğlu G, Zorlu A, Ekinözü İ, Turgut OO, Tandoğan İ, Yılmaz MB.

Anadolu Kardiyol Derg. 2014 May;14(3):306-7. No abstract available.

9.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

10.

Author's reply: To PMID 23128542.

Zorkun C, Akkaya E, Zorlu A, Tandoğan İ.

Anadolu Kardiyol Derg. 2013 Aug;13(5):503. No abstract available.

11.

Elevated mean pulmonary artery pressure in patients with mild-to-moderate mitral stenosis: a useful predictor of worsening renal functions?

Zorkun C, Amioğlu G, Bektaşoğlu G, Zorlu A, Ekinözü İ, Turgut OO, Tandoğan İ, Yılmaz MB.

Anadolu Kardiyol Derg. 2013 Aug;13(5):457-64. doi: 10.5152/akd.2013.144. Epub 2013 May 27.

12.

Central diastolic blood pressure is associated with the degree of coronary collateral development.

Ege MR, Zorlu A, Yilmaz MB, Acikgoz S, Tandogan I, Cinar Z.

Angiology. 2013 Oct;64(7):546-52. doi: 10.1177/0003319712469276. Epub 2012 Dec 23.

PMID:
23267239
13.

Determinants of coronary collateral circulation in patients with coronary artery disease.

Zorkun C, Akkaya E, Zorlu A, Tandoğan I.

Anadolu Kardiyol Derg. 2013 Mar;13(2):146-51. doi: 10.5152/akd.2012.250. Epub 2012 Nov 5.

14.

Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus.

Turgut O, Zorlu A, Kilicli F, Cinar Z, Yucel H, Tandogan I, Dokmetas HS.

Platelets. 2013;24(6):493-7. doi: 10.3109/09537104.2012.725876. Epub 2012 Sep 20.

PMID:
22994845
15.

Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?

Ege MR, Guray U, Guray Y, Yilmaz MB, Yucel O, Zorlu A, Tandogan I.

Herz. 2012 Nov;37(7):796-800. doi: 10.1007/s00059-012-3641-x. Epub 2012 Jun 16.

PMID:
22699995
16.

Effect of levosimendan in patients with severe systolic heart failure and worsening renal function.

Zorlu A, Yücel H, Yontar OC, Karahan O, Tandogan I, Katrancioglu N, Yilmaz MB.

Arq Bras Cardiol. 2012 Jun;98(6):537-43. Epub 2012 May 29. English, Portuguese.

17.

The product of eGFR and hemoglobin may help predict mortality in systolic heart failure patients without severe anemia and renal failure.

Yılmaz MB, Zorlu A, Bektaşoğlu G, Yontar OC, Tandoğan I.

Turk Kardiyol Dern Ars. 2012 Jan;40(1):9-15. doi: 10.5543/tkda.2012.01496.

18.

Increased γ-glutamyl transferase levels predict early mortality in patients with acute pulmonary embolism.

Zorlu A, Yucel H, Bektasoglu G, Turkdogan KA, Eryigit U, Sarikaya S, Ege MR, Tandogan I, Yilmaz MB.

Am J Emerg Med. 2012 Jul;30(6):908-15. doi: 10.1016/j.ajem.2011.12.040. Epub 2012 Mar 3.

PMID:
22386346
19.

The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients.

Kozan O, Ozcan EE, Sancaktar O, Kabakcı G; Turkish investigators of the i-SEARCH study.

Turk Kardiyol Dern Ars. 2011 Dec;39(8):635-45. doi: 10.5543/tkda.2011.01477.

20.

Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.

Erselcan T, Egilmez H, Hasbek Z, Tandogan I.

Acta Radiol. 2012 Mar 1;53(2):228-32. doi: 10.1258/ar.2011.110412. Epub 2011 Dec 2.

PMID:
22139722

Supplemental Content

Loading ...
Support Center